WRP Corp.
This article was originally published in The Gray Sheet
Executive Summary
Disposable medical glove maker submits appeal of Nasdaq delisting notice, to be effective May 11. The firm did not sustain compliance with Nasdaq's minimum bid requirement of $1.00 within a 90-day grace period set forth in a Feb. 2 notice. Once Nasdaq receives WRP's request for a hearing, the request "will automatically defer" the delisting until Nasdaq's hearing panel makes a ruling, WRP explains. Itasca, Illinois-based WRP "will be presenting its business plan to the hearing panel and will seek to put in place steps to avoid delisting prior to any delisting of its shares"
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.